Log in to save to my catalogue

Remifentanil versus fentanyl during cardiac surgery on the incidence of chronic thoracic pain (REFLE...

Remifentanil versus fentanyl during cardiac surgery on the incidence of chronic thoracic pain (REFLE...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4258928

Remifentanil versus fentanyl during cardiac surgery on the incidence of chronic thoracic pain (REFLECT): study protocol for a randomized controlled trial

About this item

Full title

Remifentanil versus fentanyl during cardiac surgery on the incidence of chronic thoracic pain (REFLECT): study protocol for a randomized controlled trial

Publisher

England: BioMed Central Ltd

Journal title

Trials, 2014-11, Vol.15 (1), p.466-466, Article 466

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Chronic thoracic pain after cardiac surgery is prevalent (11 to 56%) and may affect patients' physical and mental health status. Despite its favorable pharmacokinetic and pharmacodynamic properties, high doses of remifentanil administered during surgery are reported to cause acute postoperative pain and increased requirements for analgesics. Recent...

Alternative Titles

Full title

Remifentanil versus fentanyl during cardiac surgery on the incidence of chronic thoracic pain (REFLECT): study protocol for a randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4258928

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4258928

Other Identifiers

ISSN

1745-6215

E-ISSN

1745-6215

DOI

10.1186/1745-6215-15-466

How to access this item